Genetic or pharmacological perturbation of NOTCH3 conferred chemosensitivity of NPC in vitro and overexpression of NOTCH3 enhanced chemoresistance of NPC in vivo. This evidence concerns the gene NOTCH3 and nasopharyngeal carcinoma.